Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Fluxion Delivers First Commercial Shipments of IsoFlux™ System

Published: Friday, June 07, 2013
Last Updated: Friday, June 07, 2013
Bookmark and Share
Platform enables pharma, research, and diagnostic companies to utilize blood samples for cancer diagnostic breakthroughs.

Fluxion Biosciences, Inc. has announced that the first round of IsoFlux instruments has been delivered to customers around the world.

Initially announced in November, the IsoFlux System is an automated instrument and microfluidic cartridge for high sensitivity enrichment of rare cells such as circulating tumor cells (CTCs), stem cells, and immune cells.

The first 15 instrument placements included global pharma companies, emerging biotechs, and leading cancer research institutes.

"We're very pleased that after two years of research and development, the IsoFlux System is now in the hands of very capable customers," said Jeff Jensen, CEO of Fluxion.

Jensen continued, "We fully expect that the next wave of breakthroughs in cancer diagnostics will come from this group and future customers."

CTCs are cells that disseminate from primary tumors and contribute to the spread of the disease to other parts of the body.

They circulate in very low concentration in the peripheral blood and are not readily retrievable with conventional technologies.

The IsoFlux System recovers these rare tumor cells from a standard blood draw and prepares them for molecular analysis.

The platform offers improved sensitivity of CTC recovery in a low-volume format optimized for analytical platforms such as real-time quantitative PCR (qPCR), next generation sequencing (NGS), and immunofluorescence.

Initial customers have adopted the system to characterize CTCs for biomarkers including gene expression, mutations, and chromosomal aberrations.

“Our reconnaissance identified the IsoFlux instrument as a perfectly suitable technology platform for our needs in translational cancer research to analyze circulating tumor cells from patients with various cancer indications” said Dr. Norbert Kienzle at the Ingham Institute for Applied Medical Research in Sydney, Australia.

Dr. Kienzle continued, “In addition to highly sensitive recovery of CTCs and ease of system use, we need flexibility for downstream molecular and cellular analyses - the IsoFlux ticks all these boxes. Our initial hands-on experience and the constructive working relationship with Fluxion gives us confidence to go forward with our research questions on the biology and clinical utility of CTCs, ultimately aiming to improve patient outcomes in one of Sydney’s largest and fastest growing cancer populations.”

The IsoFlux System is sold globally through Fluxion in North America and a network of distributors in Europe and Asia.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Stanford University Study Shows Early Detection of CTCs in NSCLC Patients
IsoFlux System demonstrates high sensitivity CTC recovery in challenging patient group.
Tuesday, November 26, 2013
Fluxion Receives $1.2M NIH Grant for the Development of Drug Discovery Platform
Grant funds development of multiplexed single-cell electroporation system for highly controlled siRNA delivery.
Monday, May 21, 2007
Scientific News
Retractable Protein Nanoneedles
The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Cancer Drug Target Visualized at Atomic Resolution
New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.
Genetic Mechanism Behind Cancer-Causing Mutations
Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!